This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
While considering the confusing flood of drugs in the pharmacies it is hard to believe in a lack of medication. But there are still many infectious diseases and also cancer that cannot be treated sufficiently. During a medical treatment it is essential that the drug arrives at the envisaged body region. Read more about the research of the department “Drug Delivery” on techniques for the correct distribution of novel drugs.
Prof Dr Claus-Michael Lehr
The transport of active agents from the application site to the site of action plays an essential role in the successful development of new drugs. Personally, I am fascinated by the multidisciplinarity of the research approach, which reaches from molecular cell biology to macromolecular chemistry and nanotechnology.
Claus-Michael Lehr studied pharmacy at the universities of Mainz and Hamburg. After that, he wrote his PhD thesis at the Leiden University in the Netherlands. In 1991, he started as a postdoc at the University of Southern California in Los Angeles, USA, and returned to the Netherlands in the following year, where he worked at the Leiden/Amsterdam Centre for Drug Research. In 1993, Claus-Michael Lehr became professor for pharmaceutical technology at the Phillips University Marburg and, since 1995, is the head of the department Biopharmaceutics and Pharmaceutical Technology at Saarland University in Saarbrücken.
He was engaged in the founding of the Across Barriers GmbH Saarbrücken in 1998 and co-founded the Centre for Bioinformatics Saarbrücken in 2000, where he still is deputy director.
His successful research was rewarded with numerous awards, for example the International Prize of the Belgian Society of Pharmaceutical Sciences (2009) and the APV Research Award for Outstanding Achievements in the Pharmaceutical Sciences (2006).
Since 2009 Claus-Michael Lehr leads the department Drug Delivery of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and is co-founder of the PharmaBioTec GmbH in Saarbrücken.
Vaccination by inhalation
Vaccination as simple as putting on lotion
Additional space for drug research in Saarbrücken, Germany
Lung mucus gel scaffold prevents nanoparticles from getting through
The Lung in a Cell-Culture Model
Helmholtz Centre for Infection Research receives project funding from the Bill und Melinda Gates Foundation
Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!
- Kleine Teile – große Wirkung: Pharmazeuten des HIPS schleusen Medikamente zielsicher durch den Körper
Wie kommt ein Medikament dahin, wo es wirken soll? Das ist eine der zentralen Fragen bei der Entwicklung neuer Wirkstoffe. Denn es reicht nicht, ein tolles neues Medikament gegen Darminfektionen im Reagenzglas zu haben – es muss auch dort hin gelangen, wo die Krankheit stattfindet. Mit Transportmolekülen schleusen die Pharmazeuten des HZI diese Wirkstoffe durch unseren Körper – über Barrieren, durch passende Lücken und an gefährlichen Stellen vorbei. Besuchen Sie Claus-Michael Lehr und Brigitta Loretz am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS)…